Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
ACUTAAS
₹3,390
₹3373.10
₹3499.90
₹1095.40
₹3740.00
Markets Today
Historical Performance
As of 10-07-2026 20:26, Acutaas Chemicals Ltd. share price today is ₹0, with a change of ₹-3458.80 (-100.00%) from the previous close of ₹3458.8. The stock opened at ₹3485.9 and traded between ₹3373.1 and ₹3499.9, with a total traded volume of 310324 shares. The company has a market capitalization of ₹28317.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹3740 and ₹1095.4, respectively.
Acutaas Chemicals Ltd. valuation metrics include a P/E ratio of 79.5, EPS of ₹43.51, and book value of ₹17.10. Profitability indicators show ROE of 21.54%. Acutaas Chemicals Ltd. has reported revenue of ₹1339.37 Cr and net profit of ₹356.26 Cr.
Acutaas Chemicals Ltd. technical indicators include Day RSI at 58.47, Day MFI at 77.6, Day ADX at 40.5. Additional indicators include Commodity Channel Index (CCI) at 38.5 and Williams %R at -46.11. Momentum indicators show Day MACD at 135.15, Day MACD Signal Line at 146.09, DayATR at 147.4. Rate of Change indicators for Acutaas Chemicals Ltd. include ROC125 at 97.72 and ROC21 at 8.13.
Exponential moving averages include EMA5 at ₹3479.7, EMA10 at ₹3462.3, EMA12 at ₹3445.6, EMA20 at ₹3369, EMA26 at ₹3310.4, EMA50 at ₹3093.6, EMA100 at ₹2750, EMA200 at ₹2318.5. Simple moving averages include SMA5 at ₹3502.8, SMA10 at ₹3516.8, SMA20 at ₹3335.6, SMA30 at ₹3275.1, SMA50 at ₹3072.2, SMA100 at ₹2661.7, SMA150 at ₹2355.2, SMA200 at ₹2168.6.
Support levels for Acutaas Chemicals are placed at First Support ₹3388.53, Second Support ₹3318.27, Third Support ₹3268.53. Resistance levels are seen at First Resistance ₹3508.53, Second Resistance ₹3558.27, Third Resistance ₹3628.53. Acutaas Chemicals Ltd. shareholding pattern shows promoter holding at 32.66%, FII holding at 19.48%, DII holding at 0%, public holding at 28.24%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 421.77 | 390.86 | 305.19 | 205.97 | 304.16 |
| Operating Expense | 240.56 | 236.66 | 208.59 | 154.98 | 220.10 |
| Operating Profit | 181.22 | 154.19 | 96.61 | 50.99 | 84.06 |
| Depreciation | 8.83 | 9.02 | 7.72 | 7.46 | 6.56 |
| Interest | 1.07 | 0.81 | 0.57 | 0.62 | 0.38 |
| Tax | 48.79 | 39.14 | 24.39 | 14.28 | 19.97 |
| Net Profit | 137.07 | 111.57 | 72.89 | 44.65 | 62.85 |
₹3390.00
↗ Bullish Moving Average
12
↘ Bearish Moving Average
4
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 36 | 36 | 32.7 | 32.7 | 32.7 | 32.7 |
| FII | 15.5 | 16.5 | 16.9 | 16.8 | 16.7 | 19.5 |
| DII | 20.3 | 18.3 | 22.4 | 22.6 | 21.7 | 19.6 |
| Public | 28.3 | 29.2 | 28 | 27.9 | 29 | 28.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 6.23 L | 9.01 L | 69.17% |
| Week | 3.17 L | 5.75 L | 55.11% |
| 1 Month | 2.58 L | 5 L | 51.71% |
| 6 Month | 2.37 L | 5.19 L | 45.71% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Stars (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Companies with high TTM EPS Growth
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 3 quarters
Increasing profits every quarter for the past 3 quarters
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Highest Recovery from 52 Week Low
RSI indicating price strength
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Sep, 2025 | 1.5 | FINAL | 18 Sep, 2025 | Equity Share |
| 13 Sep, 2024 | 3 | FINAL | 13 Sep, 2024 | Equity Share |
| 18 Sep, 2023 | 3 | FINAL | 18 Sep, 2023 | Equity Share |
| 29 Jul, 2022 | 3 | FINAL | 01 Aug, 2022 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,429 | ₹754.95 | ₹1,265 | ₹1,805 | ₹2,523 | ₹176.50 |
| % Change | 1.55% | 0.39% | 2.48% | -0.25% | -0.36% | 2.62% |
| Revenue TTM (₹ Cr) | ₹1,753.96 | ₹2,124.33 | ₹2,192.49 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹246.74 | ₹591.79 | ₹348.91 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 94.30 | 71.60 | 75.10 | 37.10 | 54.70 | -70.30 |
| 1 Year Return | 190.14 | 31.93 | 57.98 | 43.82 | 0.21 | -14.62 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Gland Pharma Ltd.
₹ 2475.00
+0.22%
Laurus Labs Ltd.
₹ 1535.50
+1.86%
Alkem Laboratories Ltd.
₹ 5676.00
+0.49%
Biocon Ltd.
₹ 418.25
+3.64%
Divi's Laboratories Ltd.
₹ 6830.50
+0.26%
Granules India Ltd.
₹ 887.00
+0.56%
Ajanta Pharma Ltd.
₹ 3366.00
+1.77%
Zydus Lifesciences Ltd.
₹ 1152.10
-0.60%
Glenmark Pharmaceuticals Ltd.
₹ 2284.50
+0.76%
Wockhardt Ltd.
₹ 1812.80
-1.01%
Aurobindo Pharma Ltd.
₹ 1568.90
-1.17%
Sun Pharmaceutical Industries Ltd.
₹ 1932.90
-0.30%
Neuland Laboratories Ltd.
₹ 19478.00
-0.33%
Ipca Laboratories Ltd.
₹ 1780.10
+0.55%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2420.00
-1.00%
AstraZeneca Pharma India Ltd.
₹ 8115.00
+0.01%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2433.00
-0.30%
Pfizer Ltd.
₹ 4720.00
+2.83%
Abbott India Ltd.
₹ 27340.00
+2.13%
Torrent Pharmaceuticals Ltd.
₹ 4890.00
-0.17%
Lupin Ltd.
₹ 2496.00
-0.29%
Dr. Reddy's Laboratories Ltd.
₹ 1246.90
-1.78%
Cipla Ltd.
₹ 1442.00
+0.05%
By signing up I certify terms, conditions & privacy policy